This is a five-year CCSG renewal (years 29-34) for the 231-member Jonsson Comprehensive Cancer Center at UCLA. Over the past five years, there have been extensive changes, including strengthening the leadership of the Program Areas with new appointments. The Division of Basic Sciences has added the recently formed Gene Regulation Program Area, and now consists of five Program Areas: 1) Signal Transduction; 2) Molecular, Cellular & Developmental Biology; 3) Tumor Immunology;4) Viral & Chemical Carcinogenesis; and 5) Gene Regulation. The Division of Cancer Prevention & Control Research hassubstantially strengthened its two Program Areas: 1) Healthy & At-Risk Populations; and 2) Patients & Survivors. The Division of Clinical/Translational Research has added the former developmental program area, Genitourinary Oncology (formerly Prostate Oncology), and now consistsof four Program Areas: 1) Women's Cancers; 2) Hematopoietic Malignancies & Bone MarrowTransplantation;3) Genitourinary Oncology; and 4) Cancer Therapy Development (formerly Solid Tumor Oncology). New Shared Resources are proposed, including Gene Expression Core, Immunology, Tissue Array, Bioinformatics, Mass Spectrometry & Proteomics, Small Animal Imaging, and Family & Genetic Evaluation. This gives a total of 14 Shared Resources, including those continuing from the previous funding period, Flow Cytometry, Nude/SCID Mouse, Media Prep, Transgenic Mouse/Embryonic Stem Cell, Human Tissue Research Center, the BASE Unit, and the Clinical Research Unit. Significant research accomplishments over the past funding cycle include our participation in the FDA approval of Herceptin and Gleevec. Cancer focus has been strengthened considerably, as evidenced by a doubling of the ratio of NCI dollars to number of JCCC members. The number of patients enrolled on cancer therapeutic trials has increased to 5,335 over the past five years, from 3,348 during the previous funding cycle. Finally, $5,594,251 in new cancer program awards has been received during the past 18 months, including an """"""""In Vivo Imaging Center"""""""" grant, a Director's Challenge Award, and a Lung SPORE.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ciolino, Henry P
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Schools of Medicine
Los Angeles
United States
Zip Code
Lisova, Ksenia; Sergeev, Maxim; Evans-Axelsson, Susan et al. (2018) Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors. Nucl Med Biol 61:36-44
Chang, Yu-Ling; Rossetti, Maura; Vlamakis, Hera et al. (2018) A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. Mucosal Immunol :
Jia, Qingmei; Bowen, Richard; Dillon, Barbara Jane et al. (2018) Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. Sci Rep 8:7009
Kiertscher, Sylvia M; Gangalum, Pallavi R; Ibrahim, Grace et al. (2018) A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers. J Neuroimmune Pharmacol 13:219-229
Van, Christina; Condro, Michael C; Lov, Kenny et al. (2018) PACAP/PAC1 Regulation of Inflammation via Catecholaminergic Neurons in a Model of Multiple Sclerosis. J Mol Neurosci :
Leoh, Lai Sum; Kim, Yoon Kyung; Candelaria, Pierre V et al. (2018) Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma. J Immunol 200:3485-3494
Hicks, Michael R; Hiserodt, Julia; Paras, Katrina et al. (2018) ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs. Nat Cell Biol 20:46-57
Tsang, Eric J; Wu, Benjamin; Zuk, Patricia (2018) MAPK signaling has stage-dependent osteogenic effects on human adipose-derived stem cells in vitro. Connect Tissue Res 59:129-146
Waters, Lynnea R; Ahsan, Fasih M; Wolf, Dane M et al. (2018) Initial B Cell Activation Induces Metabolic Reprogramming and Mitochondrial Remodeling. iScience 5:99-109
Van Dyk, Kathleen; Bower, Julienne E; Crespi, Catherine M et al. (2018) Cognitive function following breast cancer treatment and associations with concurrent symptoms. NPJ Breast Cancer 4:25

Showing the most recent 10 out of 767 publications